Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Axfood AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 61.49B | 29x | -2.69 | SEK 299.10 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.6% Downside | Upgrade to Pro+ | |
Apotea Sverige AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 12.03B | 49.4x | SEK 116.72 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.1% Downside | Upgrade to Pro+ | ||
Viva Wine AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 3.46B | 24.5x | 0.78 | SEK 39.60 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41% Upside | Upgrade to Pro+ | |
EQL Pharma | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 2.80B | 65x | 0.71 | SEK 96.50 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.6% Upside | Upgrade to Pro+ | |
Herno Gin AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 192.41M | SEK 4.80 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
AcuCort | Spotlight | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 159.42M | -3.7x | -0.19 | SEK 0.68 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Newbury Pharmaceuticals AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 81.77M | -5.9x | -0.13 | SEK 2.59 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |